Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (23)

2024

  1. A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

    JNCI Cancer Spectrum, Vol. 8, Núm. 3

  2. Cáncer de cabeza y cuello: revisión del diagnóstico y tratamiento de la sarcopenia

    Nutrición clínica y dietética hospitalaria, Vol. 44, Núm. 2, pp. 80-89

  3. Differences in Functional Capacity between Oncologic and Non-Oncologic Populations: Reference Values

    Healthcare (Switzerland), Vol. 12, Núm. 3

  4. Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities

    Clinical and Translational Radiation Oncology, Vol. 45

  5. What is the Role of Resistance Training in Supporting Patients with Head and Neck Cancer Receiving Radiotherapy Treatment? A Systematic Review

    Journal of Science in Sport and Exercise

2022

  1. SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis

    Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 215-226

2021

  1. A retrospective study on the potential of 99mTc-HDP imaging before therapy for individualizing treatments with 223Ra-Cl2 for metastatic castration resistant prostate cancer

    Medical Physics, Vol. 48, Núm. 3, pp. 1395-1403

  2. Dependency of the remnant 131I-NaI biokinetics on the administered activity in patients with differentiated thyroid cancer

    Physica Medica, Vol. 88, pp. 45-52

2020

  1. Feasibility and limitations of quantitative SPECT for 223Ra

    Physics in Medicine and Biology, Vol. 65, Núm. 8

  2. Microdosimetry-based determination of tumour control probability curves for treatments with 225Ac-PSMA of metastatic castration resistant prostate cancer

    Physics in Medicine and Biology, Vol. 65, Núm. 23

  3. Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9

2019

  1. Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively

    Physica Medica, Vol. 65, pp. 143-149

  2. Oral and maxillary metastases: Retrospective clinical analysis of 21 cases

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 41, Núm. 3, pp. 99-108

2018

  1. Comparison of microdosimetry-based absorbed doses to control tumours and clinically obtained tumour absorbed doses in treatments with 223Ra

    Physics in Medicine and Biology, Vol. 63, Núm. 14

2017

  1. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349

2013

  1. Influencia de la existencia de una dehiscencia en un canal semicircular en el espesor óseo de los canales contralaterales

    Acta Otorrinolaringologica Espanola, Vol. 64, Núm. 2, pp. 97-101

2012

  1. Influence of aging and menopause in the origin of the superior semicircular canal dehiscence

    Otology and Neurotology, Vol. 33, Núm. 4, pp. 681-684

2010

  1. Anatomo-radiological study of the Superior Semicircular Canal Dehiscence: Radiological considerations of Superior and Posterior Semicircular Canals

    European Journal of Radiology, Vol. 76, Núm. 2, pp. 167-172

2008

  1. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene

    Neurosurgery, Vol. 62, Núm. 4, pp. 857-862

2007

  1. Diagnostic efficacy of sentinel node biopsy in oral squamous cell carcinoma. Cohort study and meta-analysis

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 12, Núm. 3, pp. 201-209